Premium
In Case You Haven't Heard
Publication year - 2018
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32198
Subject(s) - haven , safe haven , medicine , operations management , business , emergency medicine , economics , mathematics , international economics , combinatorics
Last week, we finally pinned down the list cost of Sublocade, the monthly injectable buprenorphine product approved a year ago (see ADAW , Dec. 11, 2017). It's $1,580 per monthly dose, whether it's 100 milligrams or 300 milligrams. Indivior also told us they have a “co‐pay assistance program that may reduce initial out‐of‐pocket costs for eligible (commercially insured) patients to as little as $5 each month.”